New Pill-only Regimens Cure Patients With Hardest-to-treat Hepatitis C Infection
Sunday, October 19, 2014 - 15:00
in Health & Medicine
(Vienna, October 17, 2014) Two new pill-only regimens that rapidly cure most patients with genotype 1 hepatitis C (HCV) infection could soon be widely prescribed across Europe. Two recently-published studies1,2 confirmed the efficacy and safety of combination therapy with two oral direct-acting antiviral agents (DAAs), with around 90% of patients cured after just 12-weeks of treatment. read more